However, despite the loss of KRAS transcripts seen 2 weeks after the Dox was discontinued, these cells still showed elevated YB-1 protein levels that were similar to those evident in the tumours obtained from cells in which KRASG12D expression had been sustained (Fig. 4E). This evidence concerns the gene YBX1 and neoplasm.